JP2017526916A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526916A5
JP2017526916A5 JP2017507713A JP2017507713A JP2017526916A5 JP 2017526916 A5 JP2017526916 A5 JP 2017526916A5 JP 2017507713 A JP2017507713 A JP 2017507713A JP 2017507713 A JP2017507713 A JP 2017507713A JP 2017526916 A5 JP2017526916 A5 JP 2017526916A5
Authority
JP
Japan
Prior art keywords
cancer
prl3
patient
sample
exosomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017507713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017526916A (ja
Filing date
Publication date
Priority claimed from SG10201404895XA external-priority patent/SG10201404895XA/en
Application filed filed Critical
Publication of JP2017526916A publication Critical patent/JP2017526916A/ja
Publication of JP2017526916A5 publication Critical patent/JP2017526916A5/ja
Withdrawn legal-status Critical Current

Links

JP2017507713A 2014-08-13 2015-08-13 癌の診断 Withdrawn JP2017526916A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201404895X 2014-08-13
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis
PCT/SG2015/050259 WO2016024918A1 (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Publications (2)

Publication Number Publication Date
JP2017526916A JP2017526916A (ja) 2017-09-14
JP2017526916A5 true JP2017526916A5 (enExample) 2018-09-13

Family

ID=55304429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017507713A Withdrawn JP2017526916A (ja) 2014-08-13 2015-08-13 癌の診断

Country Status (6)

Country Link
US (1) US20170234880A1 (enExample)
EP (1) EP3189333A4 (enExample)
JP (1) JP2017526916A (enExample)
CN (1) CN106716132A (enExample)
SG (2) SG10201404895XA (enExample)
WO (1) WO2016024918A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018075825A1 (en) * 2016-10-19 2018-04-26 Northwestern University Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer
CN107058556A (zh) * 2017-05-09 2017-08-18 大连海事大学 一种用于评估硫丹促癌风险的方法
CN110669764B (zh) * 2017-12-11 2020-12-11 浙江大学 一种hsa-miR-10367 miRNA序列在抗肿瘤中的应用
CN110531082A (zh) * 2018-05-25 2019-12-03 国家纳米科学中心 用于乳腺癌检测及分子分型的外泌体检测装置和应用
JPWO2022030626A1 (enExample) * 2020-08-06 2022-02-10
CN112698033A (zh) * 2020-12-09 2021-04-23 复旦大学附属中山医院 一种血源性外泌体her2的检测方法及其应用
CN118376789B (zh) * 2024-06-25 2024-09-13 南昌大学第一附属医院 一种用于诊断肺癌的检测试剂盒及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006091326A1 (en) * 2005-01-28 2006-08-31 Attogen Inc. Anti-prl-3 antibodies and methods of use thereof
JP2010530735A (ja) * 2007-05-03 2010-09-16 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 細胞内のprl−1ポリペプチドまたはprl−3ポリペプチドに結合する抗体
JP2012508577A (ja) * 2008-11-12 2012-04-12 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 表現型を決定するためのエキソソームの使用方法およびそのシステム
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
SG10201903119QA (en) * 2011-09-06 2019-05-30 Agency Science Tech & Res Polypeptide vaccine

Similar Documents

Publication Publication Date Title
JP2017526916A5 (enExample)
Hoseok et al. Lung cancer biomarkers
Harouaka et al. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications
RU2018101257A (ru) Способ детекции нуклеосом, содержащих гистоновые варианты
WO2014140933A3 (en) Method for the prognosis and treatment of cancer metastasis
JOP20200216A1 (ar) تجارب للكشف عن التنكس العصبي
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
JP2017538669A5 (enExample)
MX2017014736A (es) Metodos terapeuticos y diagnosticos para cancer.
WO2015052583A3 (en) Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
JP2017503481A5 (enExample)
MX2019005683A (es) Metodos para detectar mutaciones de adn mediante el uso de extraccion con puntas mitra.
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
HK1232290A1 (zh) 检测人类骨膜蛋白的新型测定
JP2017505897A5 (enExample)
JP2018155752A5 (enExample)
JP2015524055A5 (enExample)
JP2017524933A5 (enExample)
JP2019516104A5 (enExample)
RU2016135933A (ru) Композиция для противоракового вспомогательного лекарственного средства, содержащая средство, индуцирующее экспрессию rip3, в качестве активного ингредиента, способ скрининга противоракового вспомогательного лекарственного средства, повышающего чувствительность к противораковому лекарственному средству путем стимуляции экспрессии rip3, и способ контроля чувствительности к противораковому лекарственному средству
EP4057007A3 (en) Method for the diagnosis of breast cancer
MX2019005682A (es) Metodos y dispositivos para la deteccion del virus de la hepatitis c.
TR201007549A2 (tr) Emici boncuklar ile santrifüje gereksinimi ortadan kaldıran yoğunlaştırma yöntemi ve kitleri.
WO2015023661A3 (en) Biomarkers for prostate cancer